Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.
about
Microphysiological modeling of the reproductive tract: a fertile endeavorFemale-specific aspects in the pharmacotherapy of chronic cardiovascular diseasesPrednisolone pharmacokinetics and pharmacodynamics in relation to sex and raceSex based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analysesThe Illinois Women's Health Registry: advancing women's health research and education in Illinois, USAThe GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic PatientsPharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.HIV-1 genital shedding is suppressed in the setting of high genital antiretroviral drug concentrations throughout the menstrual cycle.Invited review: gender issues related to spaceflight: a NASA perspective.Determination of minimum alveolar concentration for isoflurane and sevoflurane in a rodent model of human metabolic syndrome.Orexin-1 receptor mediation of cocaine seeking in male and female rats.Pharmacokinetics of antiretrovirals in mucosal tissueCardiologic side effects of psychotropic drugs.Gender and its effect in cardiovascular pharmacotherapeutics: recent considerations.Blood glucose levels, insulin concentrations, and insulin resistance in healthy women and women with premenstrual syndrome: a comparative study.Sex-specific differences in CYP450 isoforms in humans.Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence.Sex-specific differences in side effects of psychotropic drugs: genes or gender?Sex differences in pharmacokinetics of antidepressants.Gender-specific differences in the central nervous system's response to anesthesia.Sex and gender influences on pharmacological response: an overview.Sex differences in the pharmacokinetics of antidepressants: influence of female sex hormones and oral contraceptives.Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.Gender differences in the effects of cardiovascular drugs.Sex differences in the pharmacokinetics and bioequivalence of the delayed-release combination of doxylamine succinate-pyridoxine hydrochloride; implications for pharmacotherapy in pregnancy.Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers.Microsomal enzyme induction and clinical aggravation of porphyria: the evaluation of human urinary 6beta-hydroxycortisol/cortisol ratio as the index of hepatic CYP3A4 activity.Pharmacokinetics and pharmacodynamic response of methylprednisolone in premenopausal renal transplant recipients.Differences in Local and Systemic TFV PK Among Premenopausal Versus Postmenopausal Women Exposed to TFV 1% Vaginal Gel.Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance.Does the phase of the menstrual cycle really matter to anaesthesia?A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics
P2860
Q26991591-8EF00EFD-9096-4507-818D-468965FDF761Q28182631-CDCB8C60-15BA-43E2-A571-91D1E1C73EBFQ28363529-217D1C4A-1F7A-4774-9E9C-D38B9C1AC7EEQ28593306-A737DE90-BA85-4CE7-94C0-DBF7F302F58FQ33763677-A7F22A49-949D-43E1-92C8-462D01F1CDA2Q33844403-A0E1FD8C-419E-431B-8F4D-CA4B535FC67FQ33888718-2AF34DE4-3E32-40C0-9EB5-711395E6F9B4Q34366639-D705AF7C-8122-47B8-A52D-30F178030D12Q34407675-2937F6B4-215D-4DE3-A4B3-D1EB0AD7AAF5Q35738954-00E70CB3-EC13-47E8-9271-934B9AEFCF5FQ35776806-D10DB419-0DAD-4D56-9DE3-03B2E61D68F2Q35838594-8EA774E0-D0FB-4F47-B266-29E0C59A900DQ36077336-B3EE6930-C89F-4D40-BFDF-D7B24CB07132Q36157925-5076A02C-1D1C-4AE5-86A1-C05455E1B09BQ37022402-AC8B0A07-809B-4142-8078-14DDE1A776B0Q37181876-BA14B101-2857-4425-BE30-7A0D3A6B0B50Q37198678-FD82D285-6C0A-4ED3-A9F2-CECE475727D1Q37598900-483DDBE0-6E98-4FE8-9D8A-276C44405935Q37824711-DCE6B9E5-BAF9-4C0C-A3EB-6A344E47AC2EQ38170002-465E53EE-664A-44FF-9755-02F065EA9061Q38214338-8D85C799-B202-4C03-995B-C5F4FDB4F18BQ38214488-35E542C8-947F-41AF-B2EA-3F3E815824F1Q38959281-AFA54D86-3589-4C6C-90A0-D9550A96FEF6Q39193538-BBDA5739-AAEB-4A5B-B5C0-2AF298AD3B4BQ39333369-D1D69EA9-9321-4335-997B-8E6E3FCAFE8BQ43836982-54DD99C4-05F9-4FB3-8325-E9A13ED661D2Q44237138-61F3FC3A-E597-45D8-BF9D-6EF8D84D07EDQ45022891-BBE667E6-33C2-4E09-B22C-92AED07E799AQ49926142-2B8E6095-85F5-473B-A797-D88AA8F24DB8Q51452446-B959A4A5-030D-417E-95FA-1ECC3E855F64Q55386273-63D89730-99A5-451E-B83C-2285E7DE4C22Q58294605-F84467DC-39C8-4CCB-A271-AA1367ACDF64
P2860
Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Physiological changes during t ...... and pharmacodynamics of drugs.
@en
type
label
Physiological changes during t ...... and pharmacodynamics of drugs.
@en
prefLabel
Physiological changes during t ...... and pharmacodynamics of drugs.
@en
P1476
Physiological changes during t ...... and pharmacodynamics of drugs.
@en
P2093
Kashuba AD
Nafziger AN
P304
P356
10.2165/00003088-199834030-00003
P577
1998-03-01T00:00:00Z
P6179
1012689470